Cervical cytological screening and human papillomavirus DNA testing in flanders

被引:8
|
作者
Sahebali, S
Depuydt, CE
Segers, K
Vereecken, AJ
Bogers, JJ
机构
[1] Lab Klin Pathol, Labo RIATOL, B-2000 Antwerp, Belgium
[2] Univ Antwerp, B-2610 Antwerp, Belgium
关键词
liquid-based cytology; cervical cancer; HPV; Belgium;
D O I
10.1179/acb.2003.58.4.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The causal relationship between genital human papillomavirus (HPV) infection and cervical dysplasia/ carcinoma has been recognised for some time. The aim of this study was to document the occurrence and distribution of HPV infection in the five provinces of the Flemish region in Belgium and to correlate the HPV DNA test results with the cytological results on simultaneously performed thin layer preparations of cervical cells. Out of a total screened group of 105107 samples, 1978 samples with cytological abnormalities were tested for HPV DNA using the MY09/MY11 consensus PCR. The mean age of the whole group was 36.9 years. The LSIL group, with a mean age of 33.6 years, was significantly younger than the other groups. There was no significant difference in HPV prevalence among the provinces. In four out of five provinces the HPV prevalence reached 100% in high-grade lesions. There is a significant increase in predominance of high-risk HPV types, with increasing abnormal cytology (17.9% WNL < 51.1% ASCUS < 83.8 % LSIL < 97.2% HSIL). Three peaks of HPV DNA positivity were observed, a first at 22 yrs (82%), a second at 47 yrs (60%) and a third in women older than 65 yrs (52%). These results shed more light on HPV prevalence in Flanders and show that the MY09/MY11 consensus primer based detection system is very suitable for the detection of HPV infections in Flanders.
引用
收藏
页码:211 / 219
页数:9
相关论文
共 50 条
  • [21] The application of human papillomavirus testing to cervical cancer screening
    Lee, HP
    Seo, SS
    [J]. YONSEI MEDICAL JOURNAL, 2002, 43 (06) : 763 - 768
  • [22] Human papillomavirus testing for primary cervical cancer screening
    Carolyn D. Runowicz
    Stephanie Garozzo
    [J]. Current Oncology Reports, 2008, 10
  • [23] Human Papillomavirus Testing for Primary Cervical Cancer Screening
    Runowicz, Carolyn D.
    Garozzo, Stephanie
    [J]. CURRENT ONCOLOGY REPORTS, 2008, 10 (06) : 533 - 537
  • [24] Role of Human Papillomavirus Testing in Screening of Cervical Neoplasia
    Angel Chao
    Yun-Hsin Tang
    Chyong-Huey Lai
    [J]. Current Obstetrics and Gynecology Reports, 2014, 3 (2) : 116 - 122
  • [25] Human papillomavirus DNA testing for cervical cancer screening in low-resource settings
    Kuhn, L
    Denny, L
    Pollack, A
    Lorincz, A
    Richart, RM
    Wright, TC
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (10) : 818 - 825
  • [26] Human papillomavirus testing for primary cervical cancer screening
    Cuzick, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (01): : 108 - 109
  • [27] Evidence for the role of human papillomavirus DNA testing in primary screening fog cervical dysplasia
    Uribe, PS
    Kaplan, KJ
    Zahn, CM
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2005, 48 (01): : 120 - 126
  • [28] Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening
    Wright, TC
    Schiffman, M
    Solomon, D
    Cox, JT
    Garcia, F
    Goldie, S
    Hatch, K
    Noller, KL
    Roach, N
    Runowicz, C
    Saslow, D
    [J]. OBSTETRICS AND GYNECOLOGY, 2004, 103 (02): : 304 - 309
  • [29] Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines
    Almonte, Maribel
    Sasieni, Peter
    Cuzick, Jack
    Snow, John
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2011, 25 (05) : 617 - 629
  • [30] HUMAN PAPILLOMAVIRUS DNA TESTING IN THE MANAGEMENT OF CERVICAL NEOPLASIA
    不详
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (24): : 2975 - 2981